Literature DB >> 6272963

Introduction to Epstein-Barr virus and lymphoproliferative diseases in immunodeficient individuals.

D T Purtilo, G Klein.   

Abstract

Entities:  

Mesh:

Year:  1981        PMID: 6272963

Source DB:  PubMed          Journal:  Cancer Res        ISSN: 0008-5472            Impact factor:   12.701


× No keyword cloud information.
  7 in total

1.  The capsid antigen of Epstein-Barr virus in nasopharyngeal carcinomas: comparison of serum antibody titre, cellular antigen content and histopathology.

Authors:  N Falser
Journal:  Arch Otorhinolaryngol       Date:  1984

2.  Cyclophosphamide immunosuppression during lymphotropic herpesvirus infection in the guinea pig model. A histopathologic and virologic study.

Authors:  S McCormick; K Dowler; J A Armstrong; G D Hsiung
Journal:  Am J Pathol       Date:  1987-06       Impact factor: 4.307

3.  Chronic active Epstein-Barr virus infection in patients with Chediak-Higashi syndrome.

Authors:  F Merino; W Henle; P Ramírez-Duque
Journal:  J Clin Immunol       Date:  1986-07       Impact factor: 8.317

4.  Epstein-Barr virus infections and DNA hybridization studies in posttransplantation lymphoma and lymphoproliferative lesions: the role of primary infection.

Authors:  M Ho; G Miller; R W Atchison; M K Breinig; J S Dummer; W Andiman; T E Starzl; R Eastman; B P Griffith; R L Hardesty
Journal:  J Infect Dis       Date:  1985-11       Impact factor: 5.226

5.  Epstein-Barr virus-specific cytotoxic T cell responses in rheumatoid arthritis patients.

Authors:  J S Gaston; A B Rickinson; M A Epstein
Journal:  Rheumatol Int       Date:  1982       Impact factor: 2.631

Review 6.  Immune deficiency as a risk factor in Epstein-Barr virus-induced malignant diseases.

Authors:  D T Purtilo; M Okano; H L Grierson
Journal:  Environ Health Perspect       Date:  1990-08       Impact factor: 9.031

Review 7.  The 1986 Walter Hubert lecture. Recent studies on a vaccine to prevent EB virus-associated cancers.

Authors:  M A Epstein
Journal:  Br J Cancer       Date:  1986-07       Impact factor: 7.640

  7 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.